About Us
PharmaTher Holdings Ltd. (OTCQB: PHRRF) (CSE: PHRM) is laser-focused on unlocking the pharmaceutical potential of KETARX™ (ketamine) and fill the global unmet medical needs for anesthesia, sedation, pain, mental health, neurological, and medical countermeasures indications.
PharmaTher owns 49% of Sairiyo Therapeutics Inc., which focuses on advancing the clinical development of an improved and patented enteric-coated orally bioavailable formulation of cepharanthine (PD-001) for viral infectious diseases and medical countermeasures.
PharmaTher owns 49% of Sairiyo Therapeutics Inc., which focuses on advancing the clinical development of an improved and patented enteric-coated orally bioavailable formulation of cepharanthine (PD-001) for viral infectious diseases and medical countermeasures.
Connect With Us
PharmaTher Holdings Ltd.
82 Richmond Street East
Toronto, Ontario Canada
M5C 1P1
82 Richmond Street East
Toronto, Ontario Canada
M5C 1P1
© COPYRIGHT 2025. PharmaTher Holdings Ltd. ALL RIGHTS RESERVED.